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Abstract
Sortase A is a transmembrane protein prominent in gram-negative bacterial strains. It is
a virulence factor that anchors other proteins, which facilitate MRSA infections. In the
long term, we plan to utilize this protein to create anti-infective drugs as antibiotic
resistance continues to become a global health issue. Starting with five NIH drug
candidates, we decided to first study Sortase A with B12 due to its historical past of
ancient civilizations using natural sources of B12 to treat infections. Our senior design is
further centered around understanding how vitamin B12 interacts with Sortase A in
vitro, particularly the binding affinity between the two. The in vitro experiments will
verify the previous in vivo studies.
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Chapter 1: Introduction
1.1 Background and Motivation
The motivation of this project is to provide a more permanent solution to MRSA
infections by surpassing the antibiotic resistance that antibiotics bring. The better
quality of life and symptom reduction of MRSA patients is the ultimate motivation for
this project. The objective of our senior design project is to test the molecular
interactions between Vitamin B12 and protein virulence factors present on
Methicillin-resistant Staphylococcus aureus (MRSA) bacteria . Ultimately, the main
long-term goal of this project is to develop more effective drugs to treat MRSA.
Overall, our senior design is centered on mechanism-based drug discovery. One of the
particular strains that are of potential focus for this project is MRSA, which transitioned
from a hospital-acquired infection to the community-acquired and livestock-acquired
infections. The hair-like virulence factor on the gram-positive bacteria, specifically cilia
or pili, are used for communication between cells. In this particular project, the
cell-to-cell communications between gram-positive bacteria and mammalian (human)
cells. Narrowing the already identified drug target library will help to identify Sortase
A, which is an enzyme that catalyzes the anchoring and interactions of cell surface
proteins.
Patients who are suffering from MRSA will greatly benefit from the development of
more effective gram-positive anti-infective drugs. This will allow patients to have a
better lifestyle and will eventually have fewer restrictions on the family and the
patients. Ethical issues in this project will be implemented to address the safety of
patients.
1.1.1 MRSA
Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a type
of Staphylococcus aureus gram-positive, round shaped bacteria that has become
resistant to many of the antibiotics used to treat ordinary S
 taphylococcus aureus
infections, including methicillin. (Siddiqui) Methicillin is an antibiotic β
 -lactam
antibiotic of the p
 enicillin class, which inhibits cell wall synthesis in bacteria.
MRSA is resistant to many antibiotics and is therefore called a “superbug”.
MRSA is the result of years of often unnecessary antibiotic use. Even when
antibiotics are used appropriately, they contribute drug-resistant bacteria
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because they do not destroy every bacterium they target. Bacteria live on an
evolutionary fast track, so germs that survive treatment with one antibiotic soon
learn to resist others. As a result, when one bacterium is resistant to an antibiotic
it survives and divides rapidly and therefore, there is a dense population of
bacteria that are resistant to antibiotics. These bacteria can also transfer the
antibiotic resistant gene to other bacterial strains, which increases resistance to
that antibiotic.
MRSA is a bacterium that causes infection in different parts of the body. Usually,
it causes a mild infection under the skin such as boils and sores. It can also cause
serious skin infections and can cause infection in surgical wounds, bloodstream,
lungs, or the urinary tract. Even though most infections of MRSA are not serious,
some of these infections can be life threatening. The common S
 taphylococcus
aureus, like MRSA, start as swollen and painful red bumps that are possibly
warm to the touch, have pus or other drainage, and accompanied by fever. Over
time, they can turn into painful abscesses that require surgery to relieve the fluid
and pain. If these infections are not on the surface of the skin, they can also cause
infections in bone, joints, surgical wounds, bloodstream, heart valves, and the
lungs. (Siddiqui, WebMD)
Most MRSA infections occur in individuals who have been in hospitals or other
health care settings. When it occurs in these settings, it's known as health
care-associated MRSA (HA-MRSA). HA-MRSA infections are typically acquired
from invasive procedures or devices, such as surgeries, intravenous tubing or
artificial joints. With time, MRSA infections have occured in the community
beyond hospitals. This is known as community-associated MRSA (CA-MRSA),
which often begins as a painful skin boil. It is spread by skin-to-skin contact.
(Zhang, Siddiqui)

1.2 Existing Technologies
Currently, anti-infectives is a new field that was started by Dr. Zhiwen Zhang, and
there are no current anti-infective drugs on the market or under research. As of now,
only antibiotics are available, and that is part of the problem due to antibiotic resistance.

1.3 Literature Review
Staphylococcus aureus Sortase A Exists as a Dimeric Protein In Vitro, Changsheng Lu,
Jie Zhu,Yun Wang,Aiko Umeda,Roshani B. Cowmeadow,Eric Lai,Gabrielle N.
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Moreno,Maria D. Person, and, and Zhiwen Zhang*, Biochemistry 2007 46 (32),
9346-9354 DOI: 10.1021/bi700519w
Simon G. Patching, Surface plasmon resonance spectroscopy for characterisation of
membrane protein–ligand interactions and its potential for drug discovery,Biochimica
et Biophysica Acta (BBA) - Biomembranes,,Volume 1838, Issue 1, Part A, 2014,, Pages
43-55,
ISSN 0005-2736, https://doi.org/10.1016/j.bbamem.2013.04.028.

1.4 Project Goals
The goals of this project included was to complete our research pipeline for developing
the mechanism-based discovery assay. We initially started off with having a thorough
understanding the basis of this project through literature review. Since, the project
pertains to five potential NIH drug candidates that were tested in vivo with our protein
target, it was important to understand which drug candidate we will be using to test the
molecular interactions between Sortase A and our drug candidate. From, there we
worked on planning how we would obtain Sortase A through protein purification.
Ideally, we wanted to obtain a high-grade purified protein in order to reduce any false
positive and false negatives that contaminants can produce when molecular interactions
are tested. We also wanted to research about what instruments can be used for testing
the molecular interactions between our Sortase A protein and our drug analyte.

1.5 Alternative Solutions
In order to prevent the spread of infection, wounds on the skin should be kept clean
and covered with sterile, dry bandages. Washing hands after contact with an infected
wound, dirty clothes, changing bandages is also recommended. Also, sharing personal
items such as t owels, washcloths, razors, and clothing can increase the chances of
infection. Along with these preventative measures, there are ways of removing bacteria
from the skin. A
 ntibacterial body wash or powder for the skin (chlorhexidine baths),
cream for inside the nose (if the infection is present there), antibacterial shampoo for the
scalp (chlorhexidine soap shower/bath procedure), germ-killing soap and ointments can
potentially remove bacteria from areas where they are in contact with the body.

1.6 Team Management and Operations
We started our project in September 2019 and will be concluding our experiments at the
end of June 2019. We budgeted our time in Fall Quarter 2019 as well as Winter Quarter
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2019 to optimizing our His-tag protein purification protocol. We then spent the bulk of
Spring Quarter 2019 analyzing our protein samples via mass spectrometry and biacore.
The majority of our budget was spent on various protein purification materials such as
Ni-NTA beads, purification buffers and Qiagen reagents. We also used a quarter of our
budget on SDS page gels and protein ladders in order to obtain better resolution in our
gel results, which detailed the presence of our protein monomer and dimer.

1.6.1 Senior Design Timeline
Figure 1. Timeline and deadlines for Senior Design Project 2018-2019.

1.6.2 Senior Design Budget
Table 1. Project Budget.
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Chapter 2: Collaborative Research
We claim that there has been no collaborative research and would like to acknowledge
as well as thank Santa Clara University for allowing us to research in the Alumni
Science, Daly Science and engineering facilities.
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Chapter 3: Project Outline and Design
3.1 Cell Culture
To make sure that we had an optimum amount of Sortase A protein to purify, we had to
practice and become proficient in cell culture techniques. The cell culture protocol is
completed in the span of three days. The first step is to transform E.coli cells with the
pET-2b plasmid that contains the sequence for Sortase A with the 6-histidine tag. After
the transformation is complete, the cells are grown on Agar plate with LB media for 48
hours. A small 5 ml culture was created by growing these E.coli cells in the incubator
shaker for 12 hours. After the small culture reached an OD of approximately 0.600, the
small culture was transferred to 1500 ml of LB with Kanamycin to grow a larger culture.
In this we also added IPTG to initiate induction, or the expression of Sortase A in the
E.coli cells. After 6-8 hours of induction, the cell culture in the LB/Kanamycin solutions
were placed in pre-weighed bottles and spun down in the centrifuge to filter out and
get the cell pellets. The cell pellets plus bottles were weighed and stored in -80oC.

3.2 Protein Purification
3.2.1 Initial Native Protein Purification Protocol
After our cell culture protocol, we needed to extract and further purify our
protein. We first purified via Ni-NTA beads with buffers (wash, elution, lysis)
that we had prepared. This protein purification method was centrifuge-based
and needed to be optimized to ensure maximum protein yield. Throughout our
optimization process, we needed to alter the time in which the cell solution was
sonicated, the pH of the lysis buffer, wash buffer, as well as the elution buffer, in
addition to the amount of time each consecutive solution was centrifuged to
avoid protein denaturation. To further prevent protein degradation, PMSF was
later added in small increments to our buffers.

3.2.2 Qiagen Fast-Start Purification
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As a cross-comparison, we used the Qiagen Ni-NTA Native Protein Fast-Start
Purification Kit to test for maximum protein yield. It should be noted that as
opposed to our original protein purification procedure, the Qiagen kit provided
us with spin columns and pre-made lysis buffers, elution buffers and wash
buffers along with solutes that needed to be dissolved. To prevent protein
degradation, we also added PMSF to each of the pre-made buffers.

3.3 SDS Page Gel
3.3.1 Changes and Specifications
Initially, we used an SDS gel apparatus and gels from Bio-rad (Hercules, CA) to
qualitatively test our protein purity. After multiple runs, we came to the
conclusion that the Bio-rad products that we used did not reach the resolution
that we desired in a gel image. Consequently, we decided to move on to use
Invitrogen gels and an invitrogen apparatus (Carlsbad, CA), which enabled us to
have a separation range of 10 kDa to 40 kDa. This allowed us to clearly see
whether we had acquired the Sortase A monomer, which is located at the 17kDa
mark, and the Sortase A dimer, which is located at the 34kDa mark.

15

Chapter 4: Materials
4.1 Cell Culture Materials
The the kanamycin was obtained from VWR (Radnor, PA) and IPTG was obtained from
US Biologicals. The rest of the materials such as the bottles and centrifuges were from
the Bioengineering labs on campus.

4.2 Protein Purification Materials
Initially, we had started using the Qiagen protocol (Germantown, MD) that consisted of
protein purification in the span of three days. This protein purification protocol was not
as accurate when tested through the and therefore we switched to Qiagen’s Fast-Start
Purification (Germantown, MD), which took 90 minutes. The Ni-NTA beads used for
anchoring the Sortase A protein is from Qiagen. The PMSF used in the lysis buffer is
also from Qiagen (Germantown, MD).

4.3 SDS Page Gel Materials
The protein ladder was obtained from invitrogen (Carlsbad, CA). This was used to
calibrate and make sure that we can identify the protein qualititatively. Initially, we had
used Bio-Rad (Hercules, CA) apparatus to run the gel, but due to compatibility issues
with the protein ladder, samples, and gel, we transitioned to the Invitrogen apparatus
(Carlsbad, CA). The running buffer and SDS Page Gel were also from Invitrogen to
make sure that there was consistency in the data (Carlsbad, CA).

4.4 Mass Spectrometry Materials
Mass spectrometry, also known as MALDI-TOF, utilized materials (buffers, solutes) and
kits provided directly from GE Healthcare (Chicago, IL).
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Chapter 5: Methods
5.1 LB & Agar Plate Preparation
We first needed to autoclave 2000 mL Erlenmeyer flask under gravity (solid) conditions.
Next, we made 500 mL of an LB and agar mixture by weighing out 7.5 g of Agar and
12.5 g of LB. We poured the weighted LB and Agar into our autoclaved Erlenmeyer
flask. We filled the Erlenmeyer flask with 500 mL of di-water and Mixed solution until
the LB and Agar completely dissolved. Afterwards, we autoclaved the LB + Agar
solution under liquid conditions for about 45 minutes and allowed it to cool once
finished. An addition of 250 uL of Kanamycin was finally added to the solution for
plasmid selection. For safety purposes, we then mixed the solution in a sterile
environment by wiping down surface and pipets with 70% ethanol and lighting an
alcohol burner. After lighting the alcohol burner, we poured 10-15 mL of solution into
each lab plate. We allowed the plates to solidify for 1 hour in sterile environment with
the lid half-way open and placed the lid over the plates and let the plates sit in sterile
environment upside-down for 1 hour. It is important to parafilm each plate and store it
in the 4 degrees Celsius fridge upside-down.

5.2 Transformation
We thawed the DNA vector and the Invitrogen - One shot Top10 Chemical Competent
E.coli kit on ice. We added 5 uL of DNA vector sample into competent cells. We mad
sure not to pipet mix the DNA vector sample into competent cell and gently tapped the
tube to mix. We heat-shocked the sample by placing them in a water bath set at 42
degrees Celsius for 30 seconds. The sample is then placed on ice for another 30 seconds.
Then, 250 uL of prewarmed Super Optimal Broth with Catabolite Repression (SOC)
media at 37 degrees Celsius to the sample and store them in the 4 degrees Celsius
fridge.

5.3 Plating Transformed Cells
Starting in a sterile environment, we pipetted 50 uL of transformation solution onto the
center of the LB + Agar plate. We then used a sterile pipet tip to spread the sample
around the LB + Agar plate while keeping the plate close to the alcohol burner. The
17

sample plate was then covered with a lid and stored upside-down in an incubator set at
37 degrees celsius. The colonies were allowed to grow for roughly 48 hours on average.
After the growth period, the sample plates were stored in a four degree refrigerator.

5.4 Creating Small Scale Culture
A 2000 mL Erlenmeyer flask was autoclaved under gravity (solid) conditions. We
created 500 mL of LB by weighing out 12.5 g of LB. The measured LB was poured into
the autoclaved Erlenmeyer flask. The Erlenmeyer flask was filled with 500 mL of
di-water and mixed in solution until the LB completely dissolve. The LB solution was
autoclaved under liquid conditions. We waited until the the LB solution cooled down to
room-temperature and then added 1:100 to 1:50 ratio of Kanamycin. We mixed the LB
solution, so that Kanamycin is distributed throughout the solution. We pipetted 5 mL
from the LB solution into a separate cell culture tube. Then, we collected the LB + Agar
plate with colonies from 4 degrees Celsius fridge and used a sterile loop or pipet tip to
pick a colony and inoculated it in the 5 mL in a sterile environment. We placed the 5 mL
small scale culture in a shaking incubator at 225 rpm at 37 degrees Celsius. The 5 mL
small scale culture grow for 26 hours. The big scale LB solution in the Erlenmeyer flask
was parafilmed and store in 4 degrees Celsius fridge. The OD of the 5 mL small scale
culture was monitored on the spectrophotometer. We used plain LB without kanamycin
as a blank. We wanted to make sure the OD is close 1 (the stationary stage of a bacteria
life cycle).

5.5 Large-Scale Culture
When the OD for the small scale culture was neat 1, we added the culture to a 1500 mL
kanamycin and LB solution. The large scale culture was then left in the shaking
incubator at 225 rpm at 37 degrees celsius for roughly 8 hours. Once the OD of the
culture reached 0.6, we collected one milliliter of the cell solution as a negative control
for SDS page steps in the future. Next, we added IPTG at a final concentration of 0.1
mM to induce cell growth. From this point, our large-scale culture was incubated at 225
rpm at 37 degrees celsius for 15-20 hours.

5.6 Qiagen Native Protein Purification Kit
Before starting the experient, the native Lysis Buffer must be prepared. The lysis buffer
must consist of lysozyme and Benzonase Nuclease. The contents of the lysozyme vial
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are dissolved in 600 µl of native Lysis Buffer. To create a 10 ml aliquot of native Lysis
Buffer, 100 µl of the lysozyme solution is added. If not used immediately, the remaining
lysozyme solution is stored at –20°C. The vial containing Benzonase® Nuclease solution
is thawed and 10 µl is added to the 10 ml aliquot of native Lysis Buffer. The cell pellet is
thawed for 15 min on ice and resuspended in 10 ml of native Lysis Buffer. They are
incubated on ice for 30 minutes and mixed 2–3 times by gently swirling the cell
suspension. The lysate is centrifuged at 14,000 x g for 30 minutes at 4°C to pellet the
cellular debris. The cell lysate supernatant is retained. The supernatant now contains
the soluble fraction of the recombinant protein. The resin is gently resuspended tin a
Fast Start Column by inverting it several times. The seal was broken at the outlet of the
column and the screw cap was opened, allowing the storage buffer to drain out. The
outlet seal must be broken before the screw cap is removed. The cell lysate supernatant
is applied to the column. The flow-through fractions are collected. The column was
washed twice with 4 ml of native Wash Buffer. Both washes were collected. The bound
6xHis-tagged protein was eluted with two 1 ml aliquots of Native Elution Buffer. Each
elution fraction was collected in a separate tube. All fractions collected were stored in
-20 degrees Celsius and analyzed by SDS page Gel Electrophoresis.

5.7 SDS Page Gel Electrophoresis
First, we started by collecting our stored supernatents from a -20 degrees celsius and
placing them all on ice to thaw out slowly. Once they were ready, we used a nanodrop
to find the concentrations of each of the different supernatants, which included two
washes and two elutions. For the nanodrop, wash buffer was used as a blank for the
Flow Through and the six washes. The Elution Buffer was used as a blank for the two
Elutions. The 26616 Protein MW Ladder and 5X dye was used. Separate samples to run
through SDS-Page gel were loaded on the gel. Each sample consisted of 48 uL of specific
sample and 12 uL of 5X dye, with the total volume of 60 uL. One liter of Running Buffer
was med by mixing the Running Buffer Powder in 1 L of di-water. We set up the
SDS-Page apparatus and poured the running buffer to overfill the gel and make sure
the running buffer is filled up to the 2 gel mark. The prepped samples were loaded on
the gel. The ladder and samples, 7 uL and 60 uL respectively, were loaded. The running
buffer was pipetted back into the gel if needed. The SDS-Page apparatus was connected
to the Power Box and we ran it at 110 V for 50 minutes. After running the gel, the Power
Box was turned off Power Box and we disconnected the SDS-Page apparatus. The
running buffer was poured in a container and stored for later use —it can be used a
total of 3 times. The plastic sheets around the gel were removed the gel was rinsed with
di-water. The gel was placed in a container of di-water and microwaved for 20-30
19

seconds. The di-water was poured out and the container was filled with LabSafe Gel
Blue. The gel was stained for 1 hour unders the incubator shaker. After 1 hour, the the
LabSafe Gel Blue was poured in an Erlenmeyer flask and parafilmed. The LabSafe Gel
Blue can be used a total of 2 times. The gel container was filled with di-water and
destained overnight under the incubator shaker. The next day, the gel was screened in
the LAS 500 imager. The images were saved and analyzed and the gel was stored in
di-water in 4 degrees Celsius .
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Chapter 6: Results and Discussion
We were able to verify the presence of Sortase A via SDS page gel and MALDI-TOF.
This in turn verified that we were able to successfully purify Sortase A. Prior to the
verification process with SDS page gel and MALDI-TOF, we sequenced our purified cell
plasmid to verify that our cells were capable of expressing the gene for Sortase A
production. We translated our DNA sequence to a protein sequence, and later found
portions of the Sortase A sequence within our own protein sequence. This sequence,
and the subsequent weight of Sortase A, is shown in Figure X. As shown below in
Figure X, we were then able to verify that the 17 kDa band, associated with the
monomer for Sortase A, and the 34 kDa band, associated with the dimer for Sortase A,
were both present throughout the gel. Lastly, in Figure X, we were able to observe a
peak for Sortase A based on its weight. Overall, our results were significant as we were
able to successful isolate and purify Sortase A in order to test its interaction with B12,
and later the four other NIH drug candidates.

Figure 2. DNA to Protein Sequence Verification
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Figure 3: SDS Page Gel Final Result

Figure 4: Mass Spectrometry Isolated Peak
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Chapter 7: Project Challenges
7.1 Purification Process
The most challenging step of our project was the purification of Sortase A protein. We
dedicated the majority of our time in lab purifying Sortase A and with our advisor
troubleshooting the protein purification procedure and materials. We encountered
challenges working with delicate instruments in lab that required specialists and lab
managers to train us and calibrate the instruments. In order to improve the purification
process and find the specific step that needed to be optimized, we troubleshooted the
procedure into three main steps: Cell growth and protein expression, protein
purification and analysis.

7.2 Qiagen protocol
The Qiagen Protocol 9. Preparation of cleared E. coli lysates under native conditions
[cite] was used for our protein purification process as the starting point. There were also
previous students purification protocol notes that we used. Since we did not obtain
meaningful results on the first purification experiment, we decided discussed possible
variations on materials and methods to achieve optimum results. This troubleshooting
process was repeated several times during this project.

7.2.1 E. coli c ells and cell growth
In order to identify transformed cells, we used competent E
 . coli
cells transformed with the plasmid pET2b. Since there were no
information if the cells were expressing Sortase A and which plates
were growing cells expressing (C) His6 tag or (N) His6 tag, we
decided to sequence the cell via a purified plamid. Initially, our
goal was to use the (N) His6 tag growing cells but we were only
able to confirm (C) His6 tag expressing cells.

7.2.1.1: Sequencing
In order to confirm we had the two variations of cells, we used Sequetech
sequencing services. We were able to confirm the number two which is a
C end his6 tag after analysing the amino acid sequence. Having this
confirmation gave us confidence that we were growing the right cells and
that they were expressing Sortase A. In order to find the location of His6
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tag, we used exPasy and located the string of six histidine amino acids,
confirming that they were on the (C) end. Once we confirmed the cells, we
had and therefore which plasmid had been used to transform these cells,
we were also able to confirm the promoter which had been induced with
the correct reagent, IPTG.

7.2.1.2 Cell growth and protein expression
7.2.1.2.1 Kanamycin
We used the diluted and aliquoted kanamycin that was available in
our lab. Because the eppendorf tubes of aliquoted kanamycin had
no dates or information about the antibiotic, we purchase
kanamycin in solid form and reconstituted to the concentration we
needed. We suspected that the kanamycin we had used from the
lab could have been expired. No improvements were noted.

7.2.1.2.2 IPTG
Similarly, we suspected that the IPTG we were using in lab from
previous projects were expired and no longer effective. We
purchased new IPTG.

7.2.1.2.3 PMSF
In order to prevent Sortase A degradation during the sonication
process, PMSF was added to the lysate.

7.2.1.2.4 Sonication
Sonication is an important step to help lyse the cells in order to
obtain the Sortase A which in embedded in the cell membrane. The
recommended instructions that we obtained from previous
experiments were to set the sonicator to alternate from 10 seconds
of sonication and 15 seconds of resting period for 20 cycles with
amplitude of 30%. Our advisor suggested that we sonicated for a
longer period of time (1 hr), by giving a longer period of rest (three
minutes) to allow the lysate to cool since the heat generated from
24

sonication can degrade proteins. We found that 30 cycles of 15
seconds of sonication and 50 seconds of rest period worked best.
Color difference in the lysate was noted as the lysate that sonicated
for a longer period of time appeared to have a more yellow color
than the previous lysates that were more clear color.

7.2.1.3 Purification Steps
7.2.1.3.1 Imidazole Concentration
The purpose of imidazole is to increase the purity by either
promoting binding of Sortase A or minimizing binding of
unwanted proteins depending on its concentration in each of the
three buffers. Imidazole has similar structure to histidine and
excessive concentrations can denature proteins. Initially, imidazole
concentration for lysis buffer was 10mM , for wash buffer was
20mM and for elution buffer was 250mM according to Qiagen. We
first adjusted to 10mM for the elution buffer and no imidazole on
washing and lysis buffer. No improvement on the results were
noted. We also tried increasing the lysis buffer imidazole
concentration from 10mM to 15mM, but no difference was
observed. therefore the initial Qiagen protocol concentrations were
maintained.

7.2.1.3.2 pH adjustment
The pH also plays a role in the binding affinity of proteins. Values
of pH above 10 or below 5.8 are not ideal. According to Qiagen
protocol, optimum pH value is 8.0 for lysis, wash and elution
buffers. We tested by changing pH to 8.5 for lysis buffer to help
lysing the cells. Without observing any changes in the results, we
kept the Qiagen recommended pH 8.0 for all three buffers.

7.2.1.3.3 Ni-NTA Beads Binding Time
We varied the binding time from two hours to four hours and also
tried binding overnight (eight to ten hours). For longer binding
periods, we also increase the time for the rotator in the washing
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step. For the overnight binding, the last wash (wash 6) was
adjusted for one hour in the rotator before centrifuge step.

7.2.1.3.4 Qiagen Fast-Start Purification Kit
After several experiments following the Qiagen protocol and
preparing our own buffers, we decided to try a purification kit
from Qiagen to save us time and allow us to obtain a high yield of
Sortase A for our experiments. The kit was certainly an
improvement and a quicker purification process. Although it
produced better results, the yield was not very significant.

7.2.1.3.5 Coomassie Blue
In order to get a clearer contrast on the SDS PAGE gel imaging and
improve the quality of the gel staining, we chose to use coomassie
Blue staining instead of common blue dye. The blue dye was
further more easily contaminated and it was not as sensitive in
terms of staining. As we have later found, Coomassie blue staining
methods resulted in clearer resolution and greater band visibility.

7.2.1.3.6 Maldi-TOF calibration
In our second experiment analysing our purified protein, we had
no meaningful results from the Maldi-TOF mass spec analysis. The
specialist was there at the time and he warned us that the
equipment needed to be calibrated, and therefore these results were
maybe incorrect. The Maldi-TOF was calibrated and also needed
some maintenance before we could rerun our analysis. It took
about a week until we were able to use it again.
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Chapter 8: Engineering Standards
8.1 Economic
We wanted to make sure that the resources and materials were used efficiently in order
to ensure that we use our budget effectively. We kept a track of the materials we used
by recording the cost of each material and when it was purchased.

8.2 Health and Safety
The engineering standards for this project were followed based on Santa Clara
University’s guidelines. Health and safety in the bioengineering labs at Santa Clara
University were implemented at all times. This was achieved through maintaining
laboratory standards and following protocols to maintain sterility in the lab to make
sure that there was no cross contamination. Public health considerations were also
taken into account by making sure that different types of wastes were disposed using
the correct protocols. Laboratory safety protocols, training for laboratory instruments,
and environmental health and safety protocols (EHS) were implemented in the labs.

8.3 Environment
In order to ensure that we are sustainable in what we use, we made sure that we used
efficient instruments that did not use extra power. Moreover, we followed the
biohazard waste and disposal protocols and laboratory protocols to make sure that we
reduce the potential harm to the environment caused by improper waste disposal.
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Chapter 9: Ethical Considerations
9.1 Team Ethics
Having a high standard of work ethics was the first priority. As a team, the work was
distributed to increase efficiency and everyone had a clear communication with each
other. There was honesty, sincerity, and hardwork in this project. Moreover, as a team,
we made sure to be cognizant about how the resources were allocated for this project in
order to stay within the budget of the grant. The two main priorities were working
effectively and ensuring the well-being and development of the team over time. This
included listening to each other, being respectful, and making sure that we
communicated effectively.

9.2 Biosafety
We also used E.coli bacterial strains instead of MRSA strains to avoid any contamination
and unintended infections. Moreover, we wanted to take precautionary measures to
maintain safety in the bioengineering labs by sterilizing all of the glassware and lab
benches before use. Cleaning methods were implemented to avoid contamination
when other experiments are performed in the lab with those materials. In this way, we
wanted to reduce the amount of cross contamination and wanted to develop a more
streamlined process.
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Chapter 10: Conclusion
10.1 Discussion
While our contribution to the anti-infective development was not the noteworthy,
purifying and isolating Sortase A was the one of the most difficult portions of the
process as there were constant challenges such as protein degradation, cell culture
instability, and cell line mutations. Having a purified Sortase A protein reduces the false
positives when testing for the interactions between Sortase A and the Vitamin B12 drug
candidate.

10.2: Next Steps
10.2.1 Fast Protein Liquid Chromatography (FPLC)
Fast Protein Liquid Chromatography is a type of liquid chromatography to
analyze a heterogenous mixture of protein samples. Our Sortase A protein can be
purified further in order to get more accurate results and better interactions with
our Vitamin B12 drug candidate.

10.2.2 Biacore
Biacore is a surface plasmon technology (SPR) that monitors molecular binding
events in real time. It is useful to measure the binding affinities,
thermodynamics, and kinetic rate constants. Once the Sortase A protein is
purified further, pur next steps is to test how our protein interacts with the
vitamin b12 drug candidate.
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